文献速递物质与行为成瘾

使用非医疗用途阿片类药物者的全因与死因别死亡率:系统综述与荟萃分析

All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

该系统综述与荟萃分析纳入124项研究(含100项原始研究),评估非医疗用途阿片类药物使用者的全因与死因别粗死亡率(CMR)和标准化死亡比(SMR)。汇总全因CMR为1.6/100人年(95%CI 1.4-1.8),全因SMR为10.0(95%CI 7.6-13.2),过量、损伤、感染及非传染性疾病均见超额死亡。

要点

  • 非医疗用途阿片类药物使用者全因SMR为10.0,显著高于同龄同性别一般人群。
  • 汇总全因CMR为1.6/100人年,异质性高(I2=99.7%),与注射用药、HIV或丙肝比例相关。
  • 超额死亡见于过量、损伤、感染性和非传染性疾病,提示需综合干预。

核心结论

  • 非医疗用途阿片类药物使用者存在显著超额死亡,其中大部分可预防。
  • 超额死亡涉及多种死因,反映该人群面临多重风险暴露,需要综合性应对措施。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、PsycINFO和Embase(2009年1月1日至2019年10月3日)及2011年发表的早期系统综述。
  • 纳入报告死亡结局的非医疗用途阿片类药物使用者队列研究,由2名成员独立筛选,随机效应模型合并数据。
  • 最终纳入124项研究(100项原始研究及24项提供额外数据的研究)。

主要发现

  • 基于99个队列共1 262 592人的汇总全因CMR为1.6/100人年(95%CI 1.4-1.8/100人年),异质性显著(I2=99.7%)。
  • 异质性与研究样本中注射阿片类药物或合并HIV感染或丙型肝炎的比例相关。
  • 基于43个队列的汇总全因SMR为10.0(95%CI 7.6-13.2)。
  • 在过量、损伤、感染性和非传染性疾病等多种死因中均观察到超额死亡。

关键数值与推荐

  • 全因CMR:1.6/100人年(95%CI 1.4-1.8/100人年),基于99个队列1 262 592人。
  • 全因SMR:10.0(95%CI 7.6-13.2),基于43个队列,比较同龄同性别一般人群。

临床怎么用

  • 临床应认识到非医疗用途阿片类药物使用者全因死亡风险约为一般人群10倍,需加强风险评估与随访。
  • 针对过量、损伤、感染及非传染性疾病等多重死因,提供综合预防与干预服务。

局限性

  • 全因CMR合并存在显著异质性(I2=99.7%),部分与注射用药及HIV/丙肝比例相关。
  • 若干世界区域该人群死因别死亡率数据仍显不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Extramedical opioid use has escalated in recent years. A better understanding of cause-specific mortality in this population is needed to inform comprehensive responses. OBJECTIVE: To estimate all-cause and cause-specific crude mortality rates (CMRs) and standardized mortality ratios (SMRs) among people using extramedical opioids, including age- and sex-specific estimates when possible. DATA SOURCES: For this systematic review and meta-analysis, MEDLINE, PsycINFO, and Embase were searched for studies published from January 1, 2009, to October 3, 2019, and an earlier systematic review on this topic published in 2011. STUDY SELECTION: Cohort studies of people using extramedical opioids and reporting mortality outcomes were screened for inclusion independently by 2 team members. DATA EXTRACTION AND SYNTHESIS: Data were extracted by a team member and checked by another team member. Study quality was assessed using a custom set of items that examined risk of bias and quality of reporting. Data were pooled using random-effects meta-analysis models. Heterogeneity was assessed using stratified meta-analyses and meta-regression. MAIN OUTCOMES AND MEASURES: Outcome measures were all-cause and cause-specific CMRs and SMRs among people using extramedical opioids compared with the general population of the same age and sex. RESULTS: Of 8683 identified studies, 124 were included in this analysis (100 primary studies and 24 studies providing additional data for primary studies). The pooled all-cause CMR, based on 99 cohorts of 1 262 592 people, was 1.6 per 100 person-years (95% CI, 1.4-1.8 per 100 person-years), with substantial heterogeneity (I2 = 99.7%). Heterogeneity was associated with the proportion of the study sample that injected opioids or was living with HIV infection or hepatitis C. The pooled all-cause SMR, based on 43 cohorts, was 10.0 (95% CI, 7.6-13.2). Excess mortality was observed across a range of causes, including overdose, injuries, and infectious and noncommunicable diseases. CONCLUSIONS AND RELEVANCE: The findings suggest that people using extramedical opioids experience significant excess mortality, much of which is preventable. The range of causes for which excess mortality was observed highlights the multiplicity of risk exposures experienced by this population and the need for comprehensive responses to address these. Better data on cause-specific mortality in this population in several world regions appear to be needed.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Larney S, Tran LT, Leung J, et al. All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2020. PMID: 31876906. doi:10.1001/jamapsychiatry.2019.4170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。